Activated Fibroblasts
Activated Fibroblasts - Related Videos
11:31
Isolation of Normal and Cancer-associated Fibroblasts from Fresh Tissues by Fluorescence Activated Cell Sorting (FACS)
0 Views •
Cited by 79 •
2013
Cancer Associated Fibroblasts (CAFs) facilitate tumor initiation, growth and progression through signaling that promotes proliferation, angiogenesis, and inflammation. Here we describe a method to isolate pure populations of normal fibroblasts and CAFs from fresh mouse and human tissues by cell sorting, using PDGFRα as a surface marker.
15:43
Experimental Generation of Carcinoma-Associated Fibroblasts (CAFs) from Human Mammary Fibroblasts
0 Views •
Cited by 25 •
2011
Carcinoma-associated fibroblasts (CAFs) rich in myofibroblasts present within the tumour stroma, play a major role in driving tumour progression. We developed a coimplantation tumour xengraft model for experimentally generating CAFs from human mammary fibroblasts. The protocol describes how to establish CAF myofibroblasts that acquire an ability to promote tumourigenesis.
07:17
3D Bioprinting Phototunable Hydrogels to Study Fibroblast Activation
0 Views •
Cited by 3 •
2023
This article describes how to 3D bioprint phototunable hydrogels to study extracellular matrix stiffening and fibroblast activation.
05:54
Rapid Culturing of Primary Murine Melanocytes and Fibroblasts: Isolating Melanocytes and Fibroblasts from Whole Murine Skin Sample
0 Views •
2023
This video describes the rapid method to isolate and culture the melanocytes and fibroblast simultaneously from the postnatal mouse pup’s skin. These cells can be maintained and manipulated in vitro to study skin cell biology, wound healing, and melanoma.
03:32
Generating Neurons by Reprogramming Human Dermal Fibroblast Cells
0 Views •
2025
The video demonstrates the generation of neurons from adult human dermal fibroblasts (aHDFs). The aHDFs are reprogrammed using a lentiviral vector carrying genes for neuronal transcription factors and short hairpin RNAs (shRNAs). The shRNAs inhibit the expression of a neuronal transcriptional repressor, and the neuronal transcription factors activate genes to differentiate aHDFs into neurons. These reprogrammed aHDFs are cultured in an early and a late neuronal conversion medium to generate...
FAQs
Transforming growth factor beta, released by tumor-associated sources, serves as a major stimulus for fibroblast activation. It promotes contractile characteristics, extracellular-matrix production, tissue remodeling, and changes in signaling output. These responses convert fibroblasts into active participants in the tumor microenvironment, where their effects extend beyond structural support to influence tumor progression.
Excess extracellular-matrix deposition changes the physical and biochemical environment surrounding tumor cells. As activated fibroblasts remodel this matrix, they help shape the tissue architecture that supports cancer-cell behavior and tumor development. Studying these matrix changes can therefore reveal how stromal remodeling contributes to invasion and identify the matrix as a potential therapeutic target.
Activated fibroblasts communicate through cytokines and growth factors as well as through structural matrix changes. These signals can affect cancer-cell growth, blood-vessel formation, and immune-cell behavior, linking stromal activity to several tumor processes. Their importance lies in coordinating interactions among connective-tissue cells, malignant cells, vascular components, and immune populations.
Fibroblast activation can arise during tissue injury, inflammation, or disease, but cancer adds tumor-derived signals that sustain a tumor-supportive stromal environment. In cancer research, this context is important because the resulting cells are examined not only for repair-related activity, but also for their effects on tumor growth, invasion, vascular development, and immune behavior.
Research on these cells helps clarify how stromal components support tumor progression rather than treating cancer cells as isolated drivers of disease. Investigators can examine relationships between fibroblast activity, extracellular-matrix remodeling, cancer-cell growth and invasion, blood-vessel formation, and immune-cell behavior. This integrated view improves understanding of the tumor microenvironment.
Findings may support strategies that alter the extracellular matrix or disrupt fibroblast-mediated therapy resistance. The rationale is that tumor-supportive stromal activity can influence both disease progression and treatment response. Targeting these fibroblast-related processes could complement approaches directed at cancer cells, although the overview identifies these possibilities as research directions rather than established treatments.